The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Cozaar 100 mg Film-coated Tablets

100 milligram(s) Film-coated tablet

Merck Sharp & Dohme Ireland (Human Health) LimitedPA1286/004/003

Main Information

Trade NameCozaar 100 mg Film-coated Tablets
Active SubstancesLosartan potassium
Strength100 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMerck Sharp & Dohme Ireland (Human Health) Limited
Licence NumberPA1286/004/003

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA01 losartan


Licence Issued16/11/2001
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceSPECIAL CONDITIONS The development of this product has complied with all measures in the agreed paediatric investigation plan P/9/2008. For the purpose of the application of Article 45(3) of Regulation EC (No) 1901/2006, all studies in the agreed paediatric investigation plan P/9/2008 were completed after the entry into force of that Regulation. The Summary of Product Characteristics reflects the results of studies conducted in compliance with this agreed paediatric investigation plan.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0003-024-003
Interchangeable List DocumentPDF of Interchangeable List
« Back